Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Boulos Haraoui

101-128 of 128 results

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

scientific article published on 01 October 2020

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double-Blind Trial

scientific article published on 18 November 2020

An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs

scientific article published on 18 October 2019

Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort.

scientific article published on 26 August 2016

Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study

scientific article published on 24 October 2017

Early Rheumatoid Arthritis Presentation, Treatment and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis.

scientific article

Quality of life issues in pediatric immune-mediated inflammatory disease

scientific article

Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

article

Important issues at heart: cardiovascular risk management in rheumatoid arthritis

scientific article published on August 1, 2013

Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis

scientific article published on 23 March 2017

Preparing for subsequent entry biologics in dermatology and rheumatology in Canada

scientific article published in September 2013

Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

scholarly article by Boulos Haraoui et al published June 2019 in Rheumatology and therapy

Dr. Roubille, et al reply

scientific article

Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years

scientific article published on 01 March 2020

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

article

Treatment strategies in early rheumatoid arthritis methotrexate management: Results from a prospective cohort

scientific article published on 21 May 2019

Is Structural Damage Evaluation by Traditional Radiographs Still Relevant in Rheumatoid Arthritis Clinical Trials?

scientific article published on November 1, 2014

From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases

scientific article published on 01 May 2010

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry

scientific article published on 19 September 2020

Limitations in the Full Reporting of Systematic Literature Review

scientific article published on 01 May 2016

Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry

scientific article published on 6 June 2019

Defining and characterizing sustained remission in patients with rheumatoid arthritis

scientific article published on 9 December 2017

What is the optimal treatment for patients with RA who fail to respond to monotherapy with methotrexate?

scientific article published on 10 June 2008

Is MRI the best method to detect response to treatment in patients with ankylosing spondylitis?

scientific article published on 01 September 2006

Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice

scientific article published on 01 August 2009

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary

scientific article published on 01 February 2019

Therapeutic targets for rheumatoid arthritis

scientific article published on 01 June 2009

From Bedside to Bench: The Effect of Quality of Life on the Immune System and the Effect of the Immune System on Quality of Life

scientific article published on November 1, 2011